Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Mer receptor tyrosine kinase promotes invasion and survival in glioblastoma multiforme.

Wang Y, Moncayo G, Morin P Jr, Xue G, Grzmil M, Lino MM, Clément-Schatlo V, Frank S, Merlo A, Hemmings BA.

Oncogene. 2013 Feb 14;32(7):872-82. doi: 10.1038/onc.2012.104. Epub 2012 Apr 2.

PMID:
22469987
2.

O6-Methylguanine-DNA methyltransferase is a novel negative effector of invasion in glioblastoma multiforme.

Chahal M, Abdulkarim B, Xu Y, Guiot MC, Easaw JC, Stifani N, Sabri S.

Mol Cancer Ther. 2012 Nov;11(11):2440-50. doi: 10.1158/1535-7163.MCT-11-0977. Epub 2012 Sep 17.

3.

MerTK inhibition is a novel therapeutic approach for glioblastoma multiforme.

Knubel KH, Pernu BM, Sufit A, Nelson S, Pierce AM, Keating AK.

Oncotarget. 2014 Mar 15;5(5):1338-51.

4.

STAT6 expression in glioblastoma promotes invasive growth.

Merk BC, Owens JL, Lopes MB, Silva CM, Hussaini IM.

BMC Cancer. 2011 May 20;11:184. doi: 10.1186/1471-2407-11-184.

5.

Overexpression of CD97 confers an invasive phenotype in glioblastoma cells and is associated with decreased survival of glioblastoma patients.

Safaee M, Clark AJ, Oh MC, Ivan ME, Bloch O, Kaur G, Sun MZ, Kim JM, Oh T, Berger MS, Parsa AT.

PLoS One. 2013 Apr 26;8(4):e62765. doi: 10.1371/journal.pone.0062765. Print 2013.

6.

MERTK Inhibition Induces Polyploidy and Promotes Cell Death and Cellular Senescence in Glioblastoma Multiforme.

Sufit A, Lee-Sherick AB, DeRyckere D, Rupji M, Dwivedi B, Varella-Garcia M, Pierce AM, Kowalski J, Wang X, Frye SV, Earp HS, Keating AK, Graham DK.

PLoS One. 2016 Oct 26;11(10):e0165107. doi: 10.1371/journal.pone.0165107. eCollection 2016.

7.

Aberrant constitutive activation of nuclear factor kappaB in glioblastoma multiforme drives invasive phenotype.

Raychaudhuri B, Han Y, Lu T, Vogelbaum MA.

J Neurooncol. 2007 Oct;85(1):39-47. Epub 2007 May 4.

PMID:
17479228
8.

Inhibition of epidermal growth factor receptor-associated tyrosine kinase blocks glioblastoma invasion of the brain.

Penar PL, Khoshyomn S, Bhushan A, Tritton TR.

Neurosurgery. 1997 Jan;40(1):141-51.

PMID:
8971836
9.

MERTK controls melanoma cell migration and survival and differentially regulates cell behavior relative to AXL.

Tworkoski KA, Platt JT, Bacchiocchi A, Bosenberg M, Boggon TJ, Stern DF.

Pigment Cell Melanoma Res. 2013 Jul;26(4):527-41. doi: 10.1111/pcmr.12110. Epub 2013 May 21.

10.

EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiforme.

Day BW, Stringer BW, Al-Ejeh F, Ting MJ, Wilson J, Ensbey KS, Jamieson PR, Bruce ZC, Lim YC, Offenhäuser C, Charmsaz S, Cooper LT, Ellacott JK, Harding A, Leveque L, Inglis P, Allan S, Walker DG, Lackmann M, Osborne G, Khanna KK, Reynolds BA, Lickliter JD, Boyd AW.

Cancer Cell. 2013 Feb 11;23(2):238-48. doi: 10.1016/j.ccr.2013.01.007.

11.
12.

Axl and growth arrest-specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme.

Hutterer M, Knyazev P, Abate A, Reschke M, Maier H, Stefanova N, Knyazeva T, Barbieri V, Reindl M, Muigg A, Kostron H, Stockhammer G, Ullrich A.

Clin Cancer Res. 2008 Jan 1;14(1):130-8. doi: 10.1158/1078-0432.CCR-07-0862.

13.

Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in mice.

Lee C, Fotovati A, Triscott J, Chen J, Venugopal C, Singhal A, Dunham C, Kerr JM, Verreault M, Yip S, Wakimoto H, Jones C, Jayanthan A, Narendran A, Singh SK, Dunn SE.

Stem Cells. 2012 Jun;30(6):1064-75. doi: 10.1002/stem.1081.

14.

Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma.

Wild-Bode C, Weller M, Rimner A, Dichgans J, Wick W.

Cancer Res. 2001 Mar 15;61(6):2744-50.

15.

Silencing of Eps8 blocks migration and invasion in human glioblastoma cell lines.

Cattaneo MG, Cappellini E, Vicentini LM.

Exp Cell Res. 2012 Sep 10;318(15):1901-12. doi: 10.1016/j.yexcr.2012.05.010. Epub 2012 Jun 8.

PMID:
22683923
16.

Suppression of Rac activity induces apoptosis of human glioma cells but not normal human astrocytes.

Senger DL, Tudan C, Guiot MC, Mazzoni IE, Molenkamp G, LeBlanc R, Antel J, Olivier A, Snipes GJ, Kaplan DR.

Cancer Res. 2002 Apr 1;62(7):2131-40.

17.

Long-term exposure to imatinib reduced cancer stem cell ability through induction of cell differentiation via activation of MAPK signaling in glioblastoma cells.

Dong Y, Han Q, Zou Y, Deng Z, Lu X, Wang X, Zhang W, Jin H, Su J, Jiang T, Ren H.

Mol Cell Biochem. 2012 Nov;370(1-2):89-102. doi: 10.1007/s11010-012-1401-0. Epub 2012 Jul 25.

PMID:
22829019
18.

Related to testes-specific, vespid, and pathogenesis protein-1 (RTVP-1) is overexpressed in gliomas and regulates the growth, survival, and invasion of glioma cells.

Rosenzweig T, Ziv-Av A, Xiang C, Lu W, Cazacu S, Taler D, Miller CG, Reich R, Shoshan Y, Anikster Y, Kazimirsky G, Sarid R, Brodie C.

Cancer Res. 2006 Apr 15;66(8):4139-48.

19.

NHERF-1: modulator of glioblastoma cell migration and invasion.

Kislin KL, McDonough WS, Eschbacher JM, Armstrong BA, Berens ME.

Neoplasia. 2009 Apr;11(4):377-87.

20.

Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression.

Micallef J, Taccone M, Mukherjee J, Croul S, Busby J, Moran MF, Guha A.

Cancer Res. 2009 Oct 1;69(19):7548-56. doi: 10.1158/0008-5472.CAN-08-4783. Epub 2009 Sep 22.

Supplemental Content

Support Center